To further confirm that SFI003 exerts antitumor activity through mTOR pathway, we investigated the effects of an mTOR inhibitor, rapamycin, on the cytotoxicity of SFI003 in CRC cells. The gene discussed is MTOR; the disease is colorectal carcinoma.